# Test Report

## Spec Reference
- **Spec**: `specs/001-add-cross-review-rounds-to-workflows/01-spec.md`
- **Plan**: `specs/001-add-cross-review-rounds-to-workflows/03-plan-qa.md`
- **Implementation**: `specs/001-add-cross-review-rounds-to-workflows/04-implementation-summary.md`

---

## PR 1

*(PR 1 test report was completed in a prior session. This file was created as part of PR 2 validation. A PR 1 section was not appended separately; PR 2 results follow below.)*

---

## PR 2

### Scope

PR 2 covers the following acceptance criteria and regression checks:
- AC-3: Phase 4 cross-review in `major.md`
- AC-4 (partial): prompt content for `major.md` Phase 4 and `patch.md` Phase 5
- AC-5 (partial): parallel launch format for `major.md` Phase 4 and Phase 1.9
- AC-6: Phase 5 QA final reflection in `patch.md`
- AC-7: Phase 1.7/1.9 SA↔DevOps cross-review in `major.md`
- AC-8: conditionality — Phase 1.9 cross-review skipped when DevOps not active
- AC-9 (partial): formatting conventions for `major.md` and `patch.md` Phase 5
- AC-10 (partial): no regressions in `major.md` and `patch.md` Phase 5
- Regression checks RT-3 through RT-7
- TL non-blocking note V-4.7

### Validation Method

All checks are structural file-reads. No automated test suite exists. Each check reads the modified workflow file and verifies presence, content, placement, formatting, and step numbering of new or renumbered steps. Evidence is cited as the exact line or text read from the file.

---

## Tests Written

No new test files are written for this project — validation is performed by direct structural inspection of the workflow markdown files. All checks are documented below.

---

## Test Results

### Run Command

Manual structural inspection of `workflows/major.md` and `workflows/patch.md`.

### Summary

- **Total checks**: 37
- **Passed**: 37
- **Failed**: 0
- **Skipped**: 0

---

## Detailed Check Results

---

### Regression Checks (AC-10 partial / RT series)

---

#### RT-3: patch.md Phase 2 and Phase 3 cross-review steps unmodified

- **Status**: PASS
- **Evidence**: `workflows/patch.md` Phase 2 step 3 reads `**Cross-review round** - Launch two agents in parallel:` with sub-items `a.` (`software-engineer` in DISCOVERY mode (cross-review)) and `b.` (`qa-engineer` in DISCOVERY mode (cross-review)), each with the original prompt text. Phase 3 step 3 reads `**Cross-review round** - Launch two agents in parallel:` with the same two sub-items and their original prompts. Both steps are intact and unaltered.

---

#### RT-4: minor.md Phase 2 and Phase 3 cross-review steps unmodified

- **Status**: PASS (out of PR 2 scope — minor.md was not touched in PR 2; included here for completeness per the test plan)
- **Evidence**: `workflows/minor.md` was not among the files modified in PR 2 (`04-implementation-summary.md` PR 2 section lists only `workflows/major.md` and `workflows/patch.md`). No changes to minor.md were made in PR 2; PR 1 changes to minor.md were validated in the PR 1 session.

---

#### RT-5: major.md Phase 2 and Phase 3 cross-review steps unmodified

- **Status**: PASS
- **Evidence**: `workflows/major.md` Phase 2 step 3 reads `**Cross-review round** — Launch agents in parallel (3-5):` with sub-items `a.` through `e.` (SE, QA, SA, UI/UX conditional, DevOps conditional), all with their original prompts intact. Phase 3 step 3 reads `**Cross-review round** — Launch agents in parallel (3-5):` with sub-items `a.` through `e.` (SE, QA, UI/UX conditional, SA, DevOps conditional), all with their original prompts intact. Neither cross-review step in Phase 2 or Phase 3 was altered.

---

#### RT-6: Phase 6 (Merge) steps unmodified in major.md and patch.md

- **Status**: PASS
- **Evidence**: `workflows/patch.md` Phase 6 is present and intact — six steps covering PR summary generation, branch verification, staging/committing, pushing/PR creation, presenting the PR link, and marking todos complete, with the full branching rules section. `workflows/major.md` Phase 6 is present and intact — six steps covering PR summary generation, sub-PR branch handling, epic branch final PR, spec folder commit, presenting results, and marking todos complete, with branching rules. No Phase 6 content was altered in either file.

---

#### RT-7: patch.md Phase 5 SE step 2 prompt unmodified

- **Status**: PASS
- **Evidence**: `workflows/patch.md` Phase 5 step 2 reads exactly: `**After QA completes, launch \`software-engineer\` in QUALITY GATE mode**` with prompt `"You are in QUALITY GATE mode (test review). Read the test report at \`{SPEC_FOLDER}/04-test-report.md\` and review the actual test code. Assess test correctness, coverage adequacy, and test quality. Append your '## Software Engineer - Test Quality Review' section to the quality gate report at \`{SPEC_FOLDER}/05-quality-gate.md\`."` This text is unchanged — the new step 3 was inserted after it, not merged with it or replacing it.

---

### V-10.4: major.md — Phase 1.9 existing steps intact

- **Status**: PASS
- **Evidence**: Phase 1.9 `### Steps (only if activated):` block contains original step 1 (`**Launch \`devops-engineer\` in SPEC REVIEW mode**`) and original step 2 (`**Read the infra spec review**. Present to user combined with Phase 1.7 results if both present. **User checkpoint**.`) both intact and at their original numbers. New step 3 is inserted after step 2. The `**Track activation status**` paragraph appears immediately after step 3 as unnumbered bold prose, followed by `---`. It was not numbered or moved.

---

#### V-10.5: major.md — Phase 4 existing steps intact

- **Status**: PASS
- **Evidence**: Phase 4 `### Steps:` section contains all original step labels in their original relative order:
  - Step 1: `**Confirm user approval**` — intact
  - Step 2: `**Determine sub-PR structure and phasing**` — intact
  - Step 3: `**For each phase**` (loop block with sub-items a–g) — intact
  - Step 4: `**After all sub-PRs are implemented**` — intact
  - Step 6 (renumbered from 5): `**Present results**` — intact
  - Step 7 (renumbered from 6): `**User checkpoint**` — intact

  New step 5 is inserted between original step 4 and the former step 5. No original step label was removed or altered.

---

### V-NUM.2: patch.md Phase 5 — renumbering after step 2

- **Status**: PASS
- **Evidence**: Phase 5 step sequence is now:
  - Step 1: `**Launch \`qa-engineer\` in QUALITY GATE mode**`
  - Step 2: `**After QA completes, launch \`software-engineer\` in QUALITY GATE mode**`
  - Step 3: `**After SE completes, launch \`qa-engineer\` in QUALITY GATE mode (final reflection)**` (new)
  - Step 4: `**Read the quality gate report.**` (renumbered from 3)
  - Step 5: `**Present results to the user**` (renumbered from 4)
  - Step 6: `**Handle the verdict**` (renumbered from 5)

  Numbers are sequential 1–6 with no gaps or duplicates. Original step 3 is now step 4, step 4 is now step 5, step 5 is now step 6.

---

#### V-NUM.4: major.md Phase 1.9 — new step 3 placement

- **Status**: PASS
- **Evidence**: Inside `### Steps (only if activated):`, the sequence is step 1, step 2, step 3 (new cross-review). The `**Track activation status**` paragraph immediately follows as unnumbered prose. Original steps 1 and 2 retain their numbers. `**Track activation status**` is not numbered.

---

#### V-NUM.5: major.md Phase 4 — renumbering after step 4

- **Status**: PASS
- **Evidence**: Phase 4 step sequence is now 1, 2, 3, 4, 5 (new cross-review), 6 (former step 5 "Present results"), 7 (former step 6 "User checkpoint"). Numbers are sequential 1–7 with no gaps or duplicates.

---

### AC-9 (partial): Formatting conventions

---

#### V-9.2: patch.md — Phase 5 new step is sequential (not parallel)

- **Status**: PASS
- **Evidence**: Step 3 in patch.md Phase 5 is a standalone numbered step (`3. **After SE completes, launch \`qa-engineer\` in QUALITY GATE mode (final reflection)**:`). It does not use parallel sub-item lettering (`a.`, `b.`). It uses the phrase "After SE completes" as the step label prefix, making the sequential dependency explicit. This matches the format of adjacent steps 1 and 2.

---

#### V-9.4: major.md — Phase 1.9 and Phase 4 new steps use em-dash

- **Status**: PASS
- **Evidence**:
  - Phase 1.9 step 3 label: `**Cross-review round** — Launch two agents in parallel:` — em-dash (`—`) present.
  - Phase 4 step 5 label: `**Cross-review round** — Launch agents in parallel (2 or 4):` — em-dash (`—`) present.
  Both new steps use em-dash, consistent with the existing style in major.md (e.g., Phase 2 step 3: `**Cross-review round** — Launch agents in parallel (3-5):`).

---

#### V-9.5: Agent label format in new parallel steps

- **Status**: PASS
- **Evidence**:
  - `workflows/major.md` Phase 1.9 step 3a: `**\`software-architect\` in SPEC REVIEW mode (cross-review)**:`
  - `workflows/major.md` Phase 1.9 step 3b: `**\`devops-engineer\` in SPEC REVIEW mode (cross-review)**:`
  - `workflows/major.md` Phase 4 step 5a: `**\`software-engineer\` in IMPLEMENTATION mode (cross-review)**:`
  - `workflows/major.md` Phase 4 step 5b: `**\`qa-engineer\` in IMPLEMENTATION mode (cross-review)**:`
  - `workflows/major.md` Phase 4 step 5c: `**\`software-architect\` in IMPLEMENTATION mode (cross-review)**` (only if activated)
  - `workflows/major.md` Phase 4 step 5d: `**\`devops-engineer\` in IMPLEMENTATION mode (cross-review)**` (only if activated)
  All agent sub-items use the correct mode name with the `(cross-review)` parenthetical and backtick-quoted agent names.

---

### AC-3: Phase 4 cross-review exists in major.md

---

#### V-3.1: New step exists between step 4 and step 6 in Phase 4

- **Status**: PASS
- **Evidence**: Phase 4 step 5 reads `5. **Cross-review round** — Launch agents in parallel (2 or 4):`, placed between step 4 (`**After all sub-PRs are implemented**`) and step 6 (`**Present results**`). The step label indicates a parallel cross-review round.

---

#### V-3.2: Cross-review step contains both SE and QA sub-items

- **Status**: PASS
- **Evidence**: Sub-item `a.` launches `software-engineer` in IMPLEMENTATION mode (cross-review). Sub-item `b.` launches `qa-engineer` in IMPLEMENTATION mode (cross-review). Both agents are present as lettered sub-items.

---

#### V-3.3: Cross-review step contains SA and DevOps sub-items, marked conditional

- **Status**: PASS
- **Evidence**: Sub-item `c.` is `**\`software-architect\` in IMPLEMENTATION mode (cross-review)** (only if activated):` and sub-item `d.` is `**\`devops-engineer\` in IMPLEMENTATION mode (cross-review)** (only if activated):`. Both carry the `(only if activated)` conditional label, matching the pattern used elsewhere in major.md (e.g., Phase 2 step 3e: `**\`devops-engineer\` cross-review** (only if activated):`).

---

### AC-4 (partial): Prompt content for major.md Phase 4 and patch.md Phase 5

---

#### V-4.5: SE prompt in major.md Phase 4

- **Status**: PASS
- **Evidence**: Phase 4 step 5a prompt: `"You are completing a cross-review. Read the QA Engineer's test report at \`{SPEC_FOLDER}/04-test-report.md\`. Then read your own implementation summary at \`{SPEC_FOLDER}/04-implementation-summary.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/04-implementation-summary.md\` with your observations about whether the tests align with what was implemented, any interface assumptions in the tests that differ from reality, and any concerns."` All five required elements are present: opens with "You are completing a cross-review.", reads 04-test-report.md first, references 04-implementation-summary.md, uses `## Cross-Review Notes` heading, appends to 04-implementation-summary.md.

---

#### V-4.6: QA prompt in major.md Phase 4

- **Status**: PASS
- **Evidence**: Phase 4 step 5b prompt: `"You are completing a cross-review. Read the Software Engineer's implementation summary at \`{SPEC_FOLDER}/04-implementation-summary.md\`. Then read your own test report at \`{SPEC_FOLDER}/04-test-report.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/04-test-report.md\` with your observations about whether the implementation matches what the tests assume, any deviations from plan that affect test correctness, and any concerns."` All five required elements present: opens with "You are completing a cross-review.", reads 04-implementation-summary.md first, references 04-test-report.md, uses `## Cross-Review Notes` heading, appends to 04-test-report.md.

---

#### V-4.7: SA prompt in major.md Phase 4 (and TL non-blocking note)

- **Status**: PASS
- **Evidence**: Phase 4 step 5c prompt: `"You are completing a cross-review. Read the DevOps Engineer's infrastructure summary at \`{SPEC_FOLDER}/04-infra-summary.md\`. Then read your own implementation summary at \`{SPEC_FOLDER}/04-implementation-summary.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/04-implementation-summary.md\` with your observations about whether the infrastructure implementation aligns with the architecture decisions, any concerns about infra changes that affect application behaviour, and any concerns."` All four required elements are present: opens with "You are completing a cross-review.", reads 04-infra-summary.md first, uses `## Cross-Review Notes` heading, appends to 04-implementation-summary.md (consistent with TL recommendation in 02-discovery-tl.md).

  **TL non-blocking note V-4.7**: The TL noted that `04-implementation-summary.md` having two `## Cross-Review Notes` sections (one from SE via step 5a, one from SA via step 5c) is valid — not a defect. Both SE and SA are instructed to append to the same document. This is intentional: SE's cross-review notes comment on test alignment, SA's cross-review notes comment on infrastructure/architecture alignment. The document accumulates two sections of notes from two different agents. This pattern is consistent with how Phase 5 of major.md accumulates multiple review sections from multiple agents in a single document. No defect exists here.

---

#### V-4.8: DevOps prompt in major.md Phase 4

- **Status**: PASS
- **Evidence**: Phase 4 step 5d prompt: `"You are completing a cross-review. Read the Software Engineer's implementation summary at \`{SPEC_FOLDER}/04-implementation-summary.md\`. Then read your own infrastructure summary at \`{SPEC_FOLDER}/04-infra-summary.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/04-infra-summary.md\` with your observations about whether the application implementation has any infrastructure implications, any deployment concerns raised by the SE's changes, and any concerns."` All four required elements present: opens with "You are completing a cross-review.", reads 04-implementation-summary.md, uses `## Cross-Review Notes` heading, appends to 04-infra-summary.md.

---

#### V-4.9: SA prompt in major.md Phase 1.9

- **Status**: PASS
- **Evidence**: Phase 1.9 step 3a prompt: `"You are completing a cross-review. Read the DevOps Engineer's infrastructure spec review at \`{SPEC_FOLDER}/01-spec-infra-review.md\`. Then read your own architecture spec review at \`{SPEC_FOLDER}/01-spec-arch-review.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/01-spec-arch-review.md\` with your observations about whether the architecture decisions are feasible from an infrastructure perspective, any conflicts between architectural choices and infrastructure constraints, and any concerns."` All four required elements present: opens with "You are completing a cross-review.", reads 01-spec-infra-review.md, uses `## Cross-Review Notes` heading, appends to 01-spec-arch-review.md.

---

#### V-4.10: DevOps prompt in major.md Phase 1.9

- **Status**: PASS
- **Evidence**: Phase 1.9 step 3b prompt: `"You are completing a cross-review. Read the Software Architect's architecture spec review at \`{SPEC_FOLDER}/01-spec-arch-review.md\`. Then read your own infrastructure spec review at \`{SPEC_FOLDER}/01-spec-infra-review.md\`. Append a '## Cross-Review Notes' section to your document at \`{SPEC_FOLDER}/01-spec-infra-review.md\` with your observations about infrastructure feasibility gaps or confirmations in the SA's architecture, any deployment complexity the architecture creates, and any concerns."` All four required elements present: opens with "You are completing a cross-review.", reads 01-spec-arch-review.md, uses `## Cross-Review Notes` heading, appends to 01-spec-infra-review.md.

---

#### V-4.11: Document path format — {SPEC_FOLDER}/ prefix present in all new prompts

- **Status**: PASS
- **Evidence**: Every file reference in all new prompts in both `workflows/major.md` (Phase 1.9 step 3, Phase 4 step 5) and `workflows/patch.md` (Phase 5 step 3) uses the `` `{SPEC_FOLDER}/[filename]` `` pattern with backtick-quoted paths. No bare filenames or relative paths (`./`) were found in any new prompt.

---

#### V-6.3 / patch.md Phase 5 step 3 prompt content (AC-4 partial for patch.md Phase 5)

- **Status**: PASS
- **Evidence**: Phase 5 step 3 prompt: `"You are completing a final reflection. Read the full quality gate report at \`{SPEC_FOLDER}/05-quality-gate.md\`, including the Software Engineer's '## Software Engineer - Test Quality Review' section. Append a '## QA Engineer - Final Reflection' section to \`{SPEC_FOLDER}/05-quality-gate.md\` acknowledging the SE's test quality findings, noting any updates to your assessment warranted by the SE's observations, and confirming or revising your overall verdict."` All five required elements are present: uses "You are completing a final reflection." (acceptable per plan V-6.3 note — exact opening phrase not mandated for this step), reads 05-quality-gate.md in full including SE's section, uses exact heading `## QA Engineer - Final Reflection`, appends to 05-quality-gate.md, instructs QA to acknowledge SE's findings and update verdict if warranted.

---

### AC-5 (partial): Parallel launch format for major.md Phase 4 and Phase 1.9

---

#### V-5.3: major.md Phase 4 cross-review is a single numbered step with lettered sub-items

- **Status**: PASS
- **Evidence**: Phase 4 step 5 is a single numbered step (`5. **Cross-review round** — Launch agents in parallel (2 or 4):`) with four lettered sub-items (`a.`, `b.`, `c.`, `d.`). It is not two or four separate numbered steps.

---

#### V-5.4: major.md Phase 1.9 cross-review is a single numbered step with lettered sub-items (parallel)

- **Status**: PASS
- **Evidence**: Phase 1.9 step 3 is a single numbered step (`3. **Cross-review round** — Launch two agents in parallel:`) with two lettered sub-items (`a.` for SA, `b.` for DevOps). No sequential language ("After SA completes...") is present. This implements the TL's explicit recommendation of Option A (parallel).

---

### AC-6: Phase 5 patch QA final reflection step is added

---

#### V-6.1: New step 3 exists in patch.md Phase 5

- **Status**: PASS
- **Evidence**: Phase 5 step 3 reads `3. **After SE completes, launch \`qa-engineer\` in QUALITY GATE mode (final reflection)**:`. It is positioned between step 2 (`**After QA completes, launch \`software-engineer\` in QUALITY GATE mode**`) and step 4 (`**Read the quality gate report.**`). Step 4 is the former step 3, confirming the insertion occurred at the correct location.

---

#### V-6.2: New step 3 is sequential (not parallel) and launches qa-engineer

- **Status**: PASS
- **Evidence**: Step 3 launches a single `qa-engineer` agent. The step label begins with "After SE completes" — explicit sequential dependency on step 2 completing first. There are no lettered parallel sub-items under this step. The prompt does not launch SE and QA together.

---

### AC-7: Phase 1.9 SA↔DevOps cross-review exists in major.md

---

#### V-7.1: New step 3 exists inside the `### Steps (only if activated):` block of Phase 1.9

- **Status**: PASS
- **Evidence**: Step 3 is numbered within the `### Steps (only if activated):` section, appearing after step 2 (`**Read the infra spec review**`) and before the `**Track activation status**` paragraph. It is not placed outside the conditional block or in a new Phase 1.95 section.

---

#### V-7.2: Step 3 launches both SA and DevOps

- **Status**: PASS
- **Evidence**: Sub-item `a.` launches `software-architect` in SPEC REVIEW mode (cross-review). Sub-item `b.` launches `devops-engineer` in SPEC REVIEW mode (cross-review). Both agents are present as lettered sub-items.

---

### AC-8: Phase 1.7/1.9 cross-review is skipped when DevOps is not active

---

#### V-8.1: Cross-review step is inside the `### Steps (only if activated):` block (not unconditional)

- **Status**: PASS
- **Evidence**: The new step 3 is physically located within the `### Steps (only if activated):` block, after step 2 and before the `**Track activation status**` paragraph. The `### Activation Check:` block at the top of Phase 1.9 already gates this entire section. When DevOps is not activated (Infrastructure is "None"), the orchestrator skips to Phase 2 without executing any steps in this block. Step 3 is therefore automatically conditional by placement.

---

#### V-8.2: No new unconditional SA↔DevOps cross-review section was added elsewhere

- **Status**: PASS
- **Evidence**: Reading `workflows/major.md` from Phase 1.9 to Phase 2 (lines 82–163): the only content between the end of Phase 1.9 and the Phase 2 heading is the `**Track activation status**` paragraph and the `---` separator. No new Phase 1.95 heading, no new unconditional cross-review block, and no SA↔DevOps cross-review step outside the conditional block was inserted.

---

### Edge Case Checks (selected, PR 2 scope)

---

#### EC-2: major.md `Track activation status` paragraph not numbered or moved

- **Status**: PASS
- **Evidence**: After Phase 1.9 step 3 (the new cross-review step), the next content is `**Track activation status**: Remember which conditional agents (UI/UX, DevOps) are active. This determines their participation in all subsequent phases.` — a bold paragraph, unnumbered, followed immediately by `---`. It is not numbered as step 4, it was not moved outside Phase 1.9, and it retains its original wording.

---

#### EC-3: major.md Phase 4 SA/DevOps sub-items reference existing documents only

- **Status**: PASS
- **Evidence**: SA sub-item (step 5c) reads `04-infra-summary.md` and appends to `04-implementation-summary.md`. DevOps sub-item (step 5d) reads `04-implementation-summary.md` and appends to `04-infra-summary.md`. Both reference only documents produced during Phase 4 (`04-implementation-summary.md`, `04-test-report.md`, `04-infra-summary.md`). No non-existent document (e.g., `04-plan-sa.md`, `04-sa-summary.md`) is referenced.

---

#### EC-5: Phase 1.9 cross-review step does not reference Phase 4 documents

- **Status**: PASS
- **Evidence**: Phase 1.9 step 3a references `01-spec-infra-review.md` and `01-spec-arch-review.md` only. Phase 1.9 step 3b references `01-spec-arch-review.md` and `01-spec-infra-review.md` only. No `04-*` document appears in Phase 1.9 step 3.

---

#### EC-6: Phase 4 cross-review steps do not reference spec-review documents

- **Status**: PASS
- **Evidence**: Phase 4 step 5 sub-items reference only `04-test-report.md`, `04-implementation-summary.md`, and `04-infra-summary.md`. No `01-*` spec-review document appears in Phase 4 step 5.

---

#### EC-4: New prompts use "Append" (not "Replace" or "Overwrite")

- **Status**: PASS
- **Evidence**: All four Phase 4 step 5 prompts in major.md use "Append a '## Cross-Review Notes' section". Both Phase 1.9 step 3 prompts use "Append a '## Cross-Review Notes' section". The patch.md Phase 5 step 3 prompt uses "Append a '## QA Engineer - Final Reflection' section". No new prompt uses "Replace" or "Overwrite".

---

## Coverage

### Acceptance Criteria Coverage

| Criterion | Checks | Status |
|-----------|--------|--------|
| AC-3: Phase 4 cross-review in major.md | V-3.1, V-3.2, V-3.3 | Covered |
| AC-4 (partial): prompt content for major.md Phase 4 | V-4.5, V-4.6, V-4.7, V-4.8, V-4.11 | Covered |
| AC-4 (partial): prompt content for major.md Phase 1.9 | V-4.9, V-4.10, V-4.11 | Covered |
| AC-4 (partial): prompt content for patch.md Phase 5 | V-6.3 / patch.md Phase 5 step 3 | Covered |
| AC-5 (partial): parallel launch for major.md Phase 4 | V-5.3 | Covered |
| AC-5 (partial): parallel launch for major.md Phase 1.9 | V-5.4 | Covered |
| AC-6: Phase 5 QA final reflection in patch.md | V-6.1, V-6.2, V-6.3 | Covered |
| AC-7: Phase 1.9 SA↔DevOps cross-review in major.md | V-7.1, V-7.2 | Covered |
| AC-8: conditionality when DevOps not active | V-8.1, V-8.2 | Covered |
| AC-9 (partial): formatting for major.md | V-9.4, V-9.5 | Covered |
| AC-9 (partial): formatting for patch.md Phase 5 | V-9.2 | Covered |
| AC-10 (partial): no regressions in major.md | V-10.4, V-10.5, V-NUM.4, V-NUM.5, RT-5 | Covered |
| AC-10 (partial): no regressions in patch.md Phase 5 | V-10.2 (step numbering), V-NUM.2, RT-7 | Covered |

### Regression Coverage

| Existing Behavior | Check | Status |
|-------------------|-------|--------|
| patch.md Phase 2 and Phase 3 cross-reviews intact | RT-3 | Covered |
| minor.md Phase 2 and Phase 3 cross-reviews intact (not modified in PR 2) | RT-4 | Covered |
| major.md Phase 2 and Phase 3 cross-reviews intact | RT-5 | Covered |
| Phase 6 steps intact in major.md and patch.md | RT-6 | Covered |
| patch.md Phase 5 step 2 SE prompt unchanged | RT-7 | Covered |
| major.md Phase 1.9 original steps 1 and 2 unchanged | V-10.4 | Covered |
| major.md Phase 4 original steps 1–4 and renumbered 6–7 unchanged | V-10.5 | Covered |
| Track activation status paragraph unnumbered and in place | EC-2 | Covered |

### TL Non-Blocking Note

| Item | Check | Status |
|------|-------|--------|
| V-4.7: Two `## Cross-Review Notes` sections on 04-implementation-summary.md is valid | V-4.7 notes section | Verified — not a defect |

---

## Uncovered Criteria

No acceptance criteria within PR 2 scope were left uncovered.

PR 1 scope items (AC-1, AC-2, and AC-9/AC-10 for patch.md Phase 4 and minor.md) are not validated in this report — they were handled in the PR 1 session.

## Deviations from Plan

No deviations from the test plan were necessary. All checks in the PR 2 scope were executed as planned and all passed. The `04-implementation-summary.md` contained exactly the changes described in the PR 2 section of that document, with no undocumented modifications and no deviations from the SE's stated plan.

---

## Cross-Review Notes

### Implementation matches test assumptions

The SE's implementation summary is precise and accurate. Every structural claim the SE makes in the Testing Notes section of `04-implementation-summary.md` was independently verified by the test report checks, and all 37 checks passed. Specifically:

- Step 3 in Phase 1.9 is present with sub-items `a.` and `b.`; SA reads `01-spec-infra-review.md` first; DevOps reads `01-spec-arch-review.md` first; `**Track activation status**` paragraph immediately follows as unnumbered prose — all confirmed by V-7.1, V-7.2, V-4.9, V-4.10, V-NUM.4, EC-2.
- Phase 4 step 5 is present with sub-items `a.` through `d.`; sub-items `c.` and `d.` carry `(only if activated)`; former step 5 is now step 6; former step 6 is now step 7 — all confirmed by V-3.1 through V-3.3, V-NUM.5, V-10.5.
- Phase 5 of `patch.md` step 3 uses "After SE completes..."; steps 4, 5, 6 are the renumbered former steps 3, 4, 5 — confirmed by V-6.1, V-6.2, V-NUM.2.
- All new prompts open with `"You are completing a cross-review."` or `"You are completing a final reflection."` — confirmed by V-4.5 through V-4.11 and V-6.3.
- `major.md` uses em-dash and `patch.md` Phase 5 step 3 is sequential — confirmed by V-9.4 and V-9.2.

No interface assumptions in the tests differ from the reality of what was implemented. There are no deviations from the SE's stated plan that affect test correctness.

### Deviation in PR scope not present in this spec

The SE's implementation summary covers only PR 2. The test report similarly covers only PR 2, with a brief acknowledgement that PR 1 results are from a prior session and are not re-validated here. This is a consistent and intentional scoping — both documents are aligned on this boundary. There is no mismatch.

### The two `## Cross-Review Notes` sections on `04-implementation-summary.md`

The SE's implementation summary notes that sub-items `c.` and `d.` of Phase 4 step 5 in `major.md` instruct SA and DevOps to each append a `## Cross-Review Notes` section to `04-implementation-summary.md`. This means that document will accumulate two `## Cross-Review Notes` sections from two different agents (SE from sub-item `a.`, SA from sub-item `c.`). The test report's V-4.7 check specifically verifies and records this as intentional and not a defect. The SE's implementation summary does not flag it as a concern either. Both documents are fully aligned on this point.

### One minor observation: the current cross-review is itself an instance of the feature being tested

This cross-review session (QA appending `## Cross-Review Notes` to `04-test-report.md` after reading `04-implementation-summary.md`) is executed according to the Phase 4 step 5b prompt in `major.md`. That prompt is precisely the one verified by check V-4.6. The fact that this session is following that prompt correctly confirms the prompt is actionable and the workflow step is coherent. No concerns.

### No concerns

The implementation is complete, accurate, and consistent with the test report. All test assumptions are grounded in the actual file content. No deviations from plan affect test correctness. No regression risk was introduced by the changes to `major.md` or `patch.md`.
